Refine Search
(4)
(29)
(66)
(96)

Tularaemia - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Tularaemia - Pipeline Review, H2 2018’, provides an overview of the Tularaemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Tularaemia, complete wit...

Aspergillosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Aspergillosis - Pipeline Review, H2 2018’, provides an overview of the Aspergillosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Aspergillosis, com...

Cryptosporidiosis - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cryptosporidiosis - Pipeline Review, H2 2018’, provides an overview of the Cryptosporidiosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptospor...

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018’, provides an overview of the Progressive Multifocal Leukoencephalopathy pipeline landscape.

The report provides comprehensive information on...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018’, provides an overview of the Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections pipeline landscape.

The re...

Acinetobacter Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acinetobacter Infections - Pipeline Review, H2 2018’, provides an overview of the Acinetobacter Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Neisseria meningitidis Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neisseria meningitidis Infections - Pipeline Review, H2 2018’, provides an overview of the Neisseria meningitidis Infections pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2018’, provides an overview of the Clostridium difficile Infections (Clostridium difficile Associated Disease) pipeline ...

Klebsiella pneumoniae Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Klebsiella pneumoniae Infections - Pipeline Review, H2 2018’, provides an overview of the Klebsiella pneumoniae Infections pipeline landscape.

The report provides comprehensive information on the therapeutics un...

Japanese Encephalitis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H2 2018’, provides an overview of the Japanese Encephalitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ja...

Measles - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Measles - Pipeline Review, H2 2018’, provides an overview of the Measles pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Measles, complete with analysi...

Yellow Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Yellow Fever - Pipeline Review, H2 2018’, provides an overview of the Yellow Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Yellow Fever, comple...

Chikungunya Fever - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chikungunya Fever - Pipeline Review, H2 2018’, provides an overview of the Chikungunya Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chikunguny...

Rotavirus Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rotavirus Infections - Pipeline Review, H2 2018’, provides an overview of the Rotavirus Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rota...

Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Pipeline Review, H2 2018’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.

The report provides comprehensive information on the...